Doctor, Professor. Xiamen City introduces overseas high-level talents (Class B), Fujian Province introduces overseas high-level talents (Class B), Fujian Province's "Hundred Talents Plan" for talent introduction, the "14th Five Year Plan" National Key R&D Program "Basic Research Conditions and Major Scientific Instrument and Equipment Research and Development" Key Special Expert Group Expert, and the Guangdong Provincial Development and Reform Commission Strategic Expert Database Expert. Graduated from the School of Pharmacy, Peking University in 2002 and 2007, with Bachelor of Science and Master of Science degrees respectively; I graduated from the School of Biology and Pharmacy at Jena University in Germany in 2011 with a PhD in Pharmacy. Postdoctoral researcher at the School of Chemical Engineering, University of California, Santa Barbara, USA from 2011 to 2014. We have collaborated with pharmaceutical companies such as Biolitec AG (Germany) and Convoy Therapeutics, Inc. (USA) to engage in the research and industrialization of drug formulations and medical biomaterials. Joined Xiamen University in 2015, dedicated to the research and industrialization of marine biomedical materials, nanocarrier drug delivery systems, and transdermal drug delivery systems. More than 40 SCI papers have been published in mainstream international journals; Applied for over 20 domestic and international patents. The bee sponge bone needle related products independently developed by the research group have entered the commercialization stage. As a new type of transdermal delivery platform technology, bee sponge bone needle and its associated technology have broad application and market prospects in cosmetics, pharmaceuticals, biologics, vaccines and other fields.